Detalhe da pesquisa
1.
Cell Therapy of Vascular and Neuropathic Complications of Diabetes: Can We Avoid Limb Amputation?
Int J Mol Sci
; 24(24)2023 Dec 15.
Artigo
em Inglês
| MEDLINE | ID: mdl-38139339
2.
PDGF Restores the Defective Phenotype of Adipose-Derived Mesenchymal Stromal Cells from Diabetic Patients.
Mol Ther
; 26(11): 2696-2709, 2018 11 07.
Artigo
em Inglês
| MEDLINE | ID: mdl-30195725
3.
Corrigendum: Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
Front Immunol
; 11: 2029, 2020.
Artigo
em Inglês
| MEDLINE | ID: mdl-32983148
4.
Cost-Effective, Safe, and Personalized Cell Therapy for Critical Limb Ischemia in Type 2 Diabetes Mellitus.
Front Immunol
; 10: 1151, 2019.
Artigo
em Inglês
| MEDLINE | ID: mdl-31231366
5.
Bottlenecks in the Efficient Use of Advanced Therapy Medicinal Products Based on Mesenchymal Stromal Cells.
Stem Cells Int
; 2015: 895714, 2015.
Artigo
em Inglês
| MEDLINE | ID: mdl-26273307
6.
Mesothelial cells: a cellular surrogate for tissue engineering of corneal endothelium.
Invest Ophthalmol Vis Sci
; 55(9): 5967-78, 2014 Aug 19.
Artigo
em Inglês
| MEDLINE | ID: mdl-25139734
7.
Adipose mesenchymal stromal cells isolated from type 2 diabetic patients display reduced fibrinolytic activity.
Diabetes
; 62(12): 4266-9, 2013 Dec.
Artigo
em Inglês
| MEDLINE | ID: mdl-24043757
8.
Erratum. Mesothelial Cells: A Cellular Surrogate for Tissue Engineering of Corneal Endothelium.
Invest Ophthalmol Vis Sci
; 56(3): 1679, 2015 Mar 09.
Artigo
em Inglês
| MEDLINE | ID: mdl-25754854